New study uses genetic profiling to predict breast cancer patients’
Researchers at the Breast Care Center at Baylor College of Medicine and The Methodist Hospital have developed a new test to predict which breast cancer tumors will respond to chemotherapy, potentially reducing unnecessary treatment for women with breast cancer, according to data presented at the American Society of Clinical Oncology annual meeting in Chicago.
Using novel DNA array technology, the study identified differences in the gene patterns from tumor samples that predict which patients would respond to treatment with the chemotherapy docetaxel, marketed under the brand name Taxotere by Aventis.
After studying pretreatment biopsies from 24 patients and their genes after treatment, results show that tumors responding to Taxotere show a different pattern than tumors that had not responded to drug therapy. In the study, 88 percent of the genes were correctly classified, said Dr. Jenny Chang, an assistant professor of medicine at Baylor. This study marks the first time microarray technology has been used to study breast cancer tumor response to a chemotherapeutic agent.
"We may have a clinically useful predictive test for chemotherapy sensitivity that may allow us to prioritize breast cancer treatment strategies based on their likelihood of success," said Chang. "This research, if validated, may lead to important advances in the treatment of breast cancer including reducing unnecessary treatment for some women, while optimizing therapy for others."
The team of investigators, led by Chang, studied thousands of genes with new DNA array technology, to find the differences between tumors that responded to Taxotere chemotherapy and those tumors that failed to respond. This finding confirmed that breast cancers are not all alike, and treatment can be tailored to individual tumors.
"We are trying not only to understand the disease, but also how a patients tumor may respond to a treatment even before we select a chemotherapy. As opposed to acquired resistance, which builds up with months of therapy, these results show that some women will be resistant to the drug from day one," Chang said. "Once confirmed in a larger study, this type of molecular profiling could have profound clinical applications in defining optimal treatment selection for each individual patient."
Chemotherapy, designed to eliminate cancer cells that have spread, is beneficial in reducing the risk of death in many patients with early breast cancer, but physicians have long had trouble figuring out which patients would benefit from the treatment, she said. As a result, some breast cancer patients needlessly receive chemotherapy after surgery. Chemotherapy can have serious side effects, including nausea, vomiting, hair loss, diarrhea, nerve damage and infections.
Stefanie Asin | EurekAlert!
The most recent press releases about innovation >>>
Die letzten 5 Focus-News des innovations-reports im Überblick:
Researchers from Göttingen University discover additional function of opsins
Animal photoreceptors capture light with photopigments. Researchers from the University of Göttingen have now discovered that these photopigments fulfill an...
Researchers embark on aerial campaign over Northeast Greenland
On 15 March, the AWI research aeroplane Polar 5 will depart for Greenland. Concentrating on the furthest northeast region of the island, an international team...
Data collected on ocean-ice interactions in the little-researched regions of the far south
The world’s second-largest ice shelf was the destination for a Polarstern expedition that ended in Punta Arenas, Chile on 14th March 2018. Oceanographers from...
At the 2018 ILA Berlin Air Show from April 25–29, the Fraunhofer Institute for Laser Technology ILT is showcasing extreme high-speed Laser Material Deposition (EHLA): A video documents how for metal components that are highly loaded, EHLA has already proved itself as an alternative to hard chrome plating, which is now allowed only under special conditions.
When the EU restricted the use of hexavalent chromium compounds to special applications requiring authorization, the move prompted a rethink in the surface...
At the ILA Berlin, hall 4, booth 202, Fraunhofer FHR will present two radar sensors for navigation support of drones. The sensors are valuable components in the implementation of autonomous flying drones: they function as obstacle detectors to prevent collisions. Radar sensors also operate reliably in restricted visibility, e.g. in foggy or dusty conditions. Due to their ability to measure distances with high precision, the radar sensors can also be used as altimeters when other sources of information such as barometers or GPS are not available or cannot operate optimally.
Drones play an increasingly important role in the area of logistics and services. Well-known logistic companies place great hope in these compact, aerial...